The DxMA wishes to thank the EMMES Group for providing the news updates listed below. For more information on any item, please click on the subject to access a PDF file.
November 2007
Rapid Test May Make Transfusion of Platelets SaferInverness Medical Innovations Agrees to Acquire ParadigmHealthAxis-Shield Launches HbA1c Assay on Abbott AxSYMBeckman Coulter to Acquire Flow Cytometry Instrumentation Business from DakoJ & J Realigns Managers, Revamps UnitsSorenson Genomics to Bring the First-Ever Retail DNA Test to MarketVentana Enters into Confientiality Agreement with RocheAbaxis Announces CLIA-Waived Comprehensive Metabolic PanelBio-Rad Introduces Chromogenic Medium in the U.S. for Rapid Screening of MRSATwo Point of Care Tests from Quest Diagnostics Receive FDA 510(k) ClearanceOctober 2007
StatSure Signs Strategic Financing and License Deals with Inverness Medical InnovationsVentana to Help Develop Pathway for Companion DiagnosticsSiemens Diagnostics and Sysmex Extend Urinalysis Distribution AgreementCancer Death Rate in U.S. FallingSiemens Announces the Release of the Rapidlab 1200 Series Version 2.0 SoftwareIL Receives FDA Clearance to Expand the Intended Use for Hemosil D-Dimer HS AssayAbbott Broadens Use of i-STAT with CLIA Waiver Granted by FDA for CHEM8+ Test CartridgeDade Behring Receives FDA Clearance for Rapid-Result Gram Positive Microbiology TestsInverness Agrees to Acquire Panbio Ltd. and Bio-State Healthcare GroupOrtho Introduces Improved Sensitivity Troponin I Assay to Help Diagnose Hearth Attack, Heart DamageSeptember 2007
Dade Behring/Siemens Deal Unlikely To Raise Major Competition Issues But Phase II Cannot Be ExcludedVentana Medical Systems Acquires Spring BioScienceInverness Agrees to Acquire MatritechNational Center for Health Statistics Issues New Summary Report Regarding US PopulationCiphergen Changes Company Name to Vermillion to Better Reflect Organization's MissionParagonDx Prepares Molecular Diagnostics Expansion with Aquisition of Gentris DiagnosticsQuest Diagnostics Introduces ClariSure Test for Identifying Chromosome Abnormalities Associated with 85 Developmental Disorders in ChildrenDiagnocure Acquires New High-Value Diagnostic Tests for Breast and Colon CancerUCLA Researchers Identify Markers that May Predict Diabetes in Still-Healthy PeopleSniff Test May Signal Disorders' Early StagesJuly 2007
Siemens to Aquire Dade BehringQIAGEN Completes Offer for Digene--Anticipates Prompt Completion of AcquisitionLuminex Unveils Next Generation Multiplex SystemDigene Enters Four-Year HPV Testing Contract with Quest DiagnosticsSiemens Announces Enhances Liver Fibrosis TestExperimental Blood Test for Prostate Cancer--Hope for a Better Test than PSAPanacea Pharmaceuticals Launches a Serum-Based Diagnostic Test for Lung CancerSiems Introduces New ADVIA 1800 Chemistry SystemSeegene Introduces DNA Test to Simultaneously Detest 18 Different Human Papillomaviruses (HPVs)Severin Schwan Currently CEO of Roche Diagnostics to Become Chief Executive of the Roche GroupJune 2007
Dade Behring Grants Sublicense to Beckman Coulter for the Use of Cardiac MarkersRoche's Hostile Bid for Ventana would Boost Its Diagnostic PortfolioRoche Makes Offer to Acquire Ventana for $75 US Dollars Per Share In CashQiagen and Digene Announce MergerFDA Approves New Rapid Test to Help Diagnost Viral MeningitisInverness To Acquire Biosite Via Cash Tender at $92.50 Per ShareAxis-Shield Launches Afinion ACR Ratio Test for Diabetic MonitoringInverness Announces Successful Completion of Tender Offer for BiositeFISH on a Chip Offers Quicker, Less Costly Cancer DiagnosisColon Cancer Proteins Show Promise for Blood TestMay 2007
Merck Healthcare Executive, Peter Loscher, Picked to Run SiemensHologic and CYTYC to Merge Creating a $10 Billion Company Focused on Women's HealthcareLabCorp to be First Commercial Laboratory to Offer FDA Approved, Fully Automated Real-Time HIV Test from Roche DiagnosticsStudy Reveals PNA FISH Significantly Reduces Mortality Associated with S. Aureus Bloodstream Infections in the ICUHPV Test Market Expected to BoomInverness to Acquire Biosite Via Cash Tender at $92.50 Per ShareUK Researchers Identify Potential Marker for Pre-eclampsia in Pregnant WomenBeckman Coulter Launches the UniCel DxI 600, Targeted to Mid-Volume LabsSimple Home Spit Test to Spot Deadly Pre-EclampsiaOrtho-Clinical Diagnostics Issues Voluntary Recall for Cardiac Marker
The Emmes Group is a strategic business development, assessment and planning organization specializing in the support of firms engaged in the technology, internet, biotechnology and pharmaceutical industries. Our partners have over 50 years of combined experience in serving technology, internet and healthcare companies. For more information, click here.
